1. Cloning, Purification, and Characterization of the Catalytic C-Terminal Domain of the Human 3-Hydroxy-3-methyl glutaryl-CoA Reductase: An Effective, Fast, and Easy Method for Testing Hypocholesterolemic Compounds
- Author
-
Loredana Capobianco, Luigina Muto, Anna Napoli, Rosita Curcio, Carlo Siciliano, Giuseppe Fiermonte, Anna Rita Cappello, Vincenza Dolce, Emanuela Martello, Donatella Aiello, Angelo Vozza, Curcio, R., Aiello, D., Vozza, A., Muto, L., Martello, E., Cappello, A. R., Capobianco, L., Fiermonte, G., Siciliano C., A, Napoli, A., and Dolce, V.
- Subjects
0106 biological sciences ,Lysis ,Drug Evaluation, Preclinical ,Gene Expression ,Bioengineering ,Reductase ,Affinity chromatography, Bacterial expression, Enzymatic activity, HMGR, MALDI MS and MS/MS, Screening of statin-like molecules ,medicine.disease_cause ,01 natural sciences ,Applied Microbiology and Biotechnology ,Biochemistry ,Chromatography, Affinity ,law.invention ,03 medical and health sciences ,Affinity chromatography ,Tandem Mass Spectrometry ,law ,Catalytic Domain ,010608 biotechnology ,Escherichia coli ,medicine ,Humans ,Amino Acid Sequence ,Cloning, Molecular ,Molecular Biology ,Enzyme Assays ,030304 developmental biology ,chemistry.chemical_classification ,0303 health sciences ,Chemistry ,C-terminus ,Recombinant Proteins ,Enzyme ,Recombinant DNA ,Hydroxymethylglutaryl CoA Reductases ,Specific activity ,Hydroxymethylglutaryl-CoA Reductase Inhibitors ,Biotechnology - Abstract
3-hydroxy-3-methyl glutaryl-CoA reductase, also known as HMGR, plays a crucial role in regulating cholesterol biosynthesis and represents the main pharmacological target of statins. In mammals, this enzyme localizes to the endoplasmic reticulum membrane. HMGR includes different regions, an integral N-terminal domain connected by a linker-region to a cytosolic C-terminal domain, the latter being responsible for enzymatic activity. The aim of this work was to design a simple strategy for cloning, expression, and purification of the catalytic C-terminal domain of the human HMGR (cf-HMGR), in order to spectrophotometrically test its enzymatic activity. The recombinant cf-HMGR protein was heterologously expressed in Escherichia coli, purified by Ni+-agarose affinity chromatography and reconstituted in its active form. MALDI mass spectrometry was adopted to monitor purification procedure as a technique orthogonal to the classical Western blot analysis. Protein identity was validated by MS and MS/MS analysis, confirming about 82% of the recombinant sequence. The specific activity of the purified and dialyzed cf-HMGR preparation was enriched about 85-fold with respect to the supernatant obtained from cell lysate. The effective, cheap, and easy method here described could be useful for screening statin-like molecules, so simplifying the search for new drugs with hypocholesterolemic effects.
- Published
- 2019
- Full Text
- View/download PDF